US 8242145
Cyclic diaryl ether compounds as antagonists of prostaglandin D2 receptors
granted A61PA61P1/00A61P1/04
Quick answer
US patent 8242145 (Cyclic diaryl ether compounds as antagonists of prostaglandin D2 receptors) held by Panmira Pharmaceuticals, LLC expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Panmira Pharmaceuticals, LLC
- Grant date
- Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P11/00, A61P11/02